Atlas FDA

Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account

Medical Diagnostic Technologies, Inc. · Predicate Candidate Screening

57 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

52 daysmedian FDA review time
146 days90th percentile
57clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K062229CTC WORKSTATION, MODEL 2200Medical Diagnostic Technologies, Inc.2006-09-11400
K972209SPECTROLYSE HEPARIN (ANTI-IIA)Medical Diagnostic Technologies, Inc.1997-08-12620
K963106CHROMOLIZE PAI-1 KITMedical Diagnostic Technologies, Inc.1996-11-18980
K960871SPECTROLYSE ANTITHROMBIN III (ANTI-XA)Medical Diagnostic Technologies, Inc.1996-08-141630
K962489CHROMOLIZE TPA ASSAY KITMedical Diagnostic Technologies, Inc.1996-07-31350
K960438TINTELIZE PAI-1 KITMedical Diagnostic Technologies, Inc.1996-06-051260
K961724U-DOA CONTROLSMedical Diagnostic Technologies, Inc.1996-06-03310
K961370LA POSITIVE CONTROL PLASMAMedical Diagnostic Technologies, Inc.1996-05-24450
K955115VENOM TIEM REAGENTMedical Diagnostic Technologies, Inc.1996-04-031460
K955738BIOCLOT PROTEIN SMedical Diagnostic Technologies, Inc.1996-02-29760
K952746ALKALINE PHOSPHATASE REAGENT SYSTEMMedical Diagnostic Technologies, Inc.1995-11-271640
K952743ASPARTATE AMINOTRANSFERASE REAGENT SYSTEMMedical Diagnostic Technologies, Inc.1995-09-291050
K952741TRIGLYCERIDES (GLYCEROL BLANKING) REAGENT SYSTEMMedical Diagnostic Technologies, Inc.1995-08-17620
K952742BLOOD UREA NITROGEN REAGENT SYSTEMMedical Diagnostic Technologies, Inc.1995-08-11560
K952745CREATINE KINASE REAGENT SYSTEMMedical Diagnostic Technologies, Inc.1995-08-11560
K952744ALANINE AMINOTRANSFERASE REAGENT SYSTEMMedical Diagnostic Technologies, Inc.1995-08-07520
K952747LACTATE DEHYDROGENASE REAGENT SYSTEMMedical Diagnostic Technologies, Inc.1995-08-07520
K942093REMEL RIM STREPTOCOCCUS GROUPING LATEX AGGLUTINATION TESTMedical Diagnostic Technologies, Inc.1994-11-282100
K942257DOA-PLUS, DRUGS OF ABUSE CONTROLSMedical Diagnostic Technologies, Inc.1994-09-141280
K940457LIPASE REAGENT SYSTEMMedical Diagnostic Technologies, Inc.1994-06-021210
K935285DRUGS OF ABUSE CONTROLSMedical Diagnostic Technologies, Inc.1994-03-221390
K934351APTT-ES REAGENTMedical Diagnostic Technologies, Inc.1993-12-06900
K921556MYCOPLASMA PNEUMONIAE IGG/IGM ANTIBODY TEST SYSTEMMedical Diagnostic Technologies, Inc.1992-06-29890
K920981RISTOCETIN COFACTOR ASSAY/VON WILLEBRAND FACT ASSAMedical Diagnostic Technologies, Inc.1992-04-17460
K911145BORRELIA BURGDORFERI POLYVAL IGG/IGM ANTIBODY TESTMedical Diagnostic Technologies, Inc.1991-05-10700
K910286PLATELET AGGREGATION REAGENTSMedical Diagnostic Technologies, Inc.1991-03-19560
K904501MYCOPLASMA PNEUMONIAE ANTIBODY TEST SYSTEMMedical Diagnostic Technologies, Inc.1991-02-261470
K905203COAGULATION REFERENCE PLASMA, NORMALMedical Diagnostic Technologies, Inc.1990-12-28380
K900782HEPARIN CONTROL PLASMA, FOR USE IN APTTMedical Diagnostic Technologies, Inc.1990-03-27350
K900792RISTOCETINMedical Diagnostic Technologies, Inc.1990-03-27350
K900049APTT-EA REAGENT, AN ELLAGIC ACID ACTIVATED REAGENTMedical Diagnostic Technologies, Inc.1990-01-25220
K900133FACTOR II DEFICIENT PLASMAMedical Diagnostic Technologies, Inc.1990-01-25150
K896625THROMBOPLASTIN, FOR USE IN PROTHROMBIN TIME DETER.Medical Diagnostic Technologies, Inc.1989-12-11200
K896052FIBRINOGEN ASSAY KITMedical Diagnostic Technologies, Inc.1989-11-09220
K896033FDP COLLECTION TUBESMedical Diagnostic Technologies, Inc.1989-10-27110
K895255APTT-P REAGENT, A PARTICLE ACTIVATED REAGENTMedical Diagnostic Technologies, Inc.1989-10-06460
K895260ABNORMAL COAGULATION CONTROL PLASMA-1 (ACCP-1)Medical Diagnostic Technologies, Inc.1989-10-06450
K895261ABNORMAL COAGULATION CONTROL PLASMA-2 (ACCP-2)Medical Diagnostic Technologies, Inc.1989-10-06450
K895262NORMAL COAGULATION CONTROL PLASMA (NCCP)Medical Diagnostic Technologies, Inc.1989-10-06450
K895503ABNORMAL REFERENCE PLASMA-VIIIMedical Diagnostic Technologies, Inc.1989-10-06240
K895504ABNORMAL REFERENCE PLASMA-IXMedical Diagnostic Technologies, Inc.1989-10-06240
K893523FACTOR X DEFICIENT PLASMAMedical Diagnostic Technologies, Inc.1989-06-23460
K893524FACTOR IX DEFICIENT PLASMAMedical Diagnostic Technologies, Inc.1989-06-23460
K893525FACTOR VIII DEFICIENT PLASMAMedical Diagnostic Technologies, Inc.1989-06-23460
K893533FACTOR V DEFICIENT PLASMAMedical Diagnostic Technologies, Inc.1989-06-23460
K893534FACTOR XII DEFICIENT PLASMAMedical Diagnostic Technologies, Inc.1989-06-23460
K893535FACTOR VII DEFICIENT PLASMAMedical Diagnostic Technologies, Inc.1989-06-23460
K893536FACTOR XI DEFICIENT PLASMAMedical Diagnostic Technologies, Inc.1989-06-23460
K885290BORRELIA BURGDORFERI POLYVALENT IGG/IGM ANTIBODYMedical Diagnostic Technologies, Inc.1989-04-101040
K885293BORRELIA BURGDORFERI IGG ANTIBODY TEST SYSTEMMedical Diagnostic Technologies, Inc.1989-04-101040

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda